• Episode 22 - Dr. Michael Hayden and PROOF-HD

  • 2021/02/01
  • 再生時間： 58 分
  • ポッドキャスト

Episode 22 - Dr. Michael Hayden and PROOF-HD

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Dr. Michael Hayden, Chief Executive Officer for Prilenia Therapeutics, and a Killam Professor at the University of British Columbia, joined the HD Insights Podcast to discuss the PROOF-HD clinical study. Prilenia (https://www.prilenia.com) is sponsor for the currently active PROOF-HD trial, a global study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease. Dr. Hayden spoke about this new study's unique endpoint for total functional capacity. You will also want to hear his inspiring personal journey that led him into Huntington disease research growing up in South Africa.

    For more information on PROOF-HD, visit https://huntingtonstudygroup.org/proof-hd/.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Dr. Michael Hayden, Chief Executive Officer for Prilenia Therapeutics, and a Killam Professor at the University of British Columbia, joined the HD Insights Podcast to discuss the PROOF-HD clinical study. Prilenia (https://www.prilenia.com) is sponsor for the currently active PROOF-HD trial, a global study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease. Dr. Hayden spoke about this new study's unique endpoint for total functional capacity. You will also want to hear his inspiring personal journey that led him into Huntington disease research growing up in South Africa.

For more information on PROOF-HD, visit https://huntingtonstudygroup.org/proof-hd/.
科学
続きを読む 一部表示

Episode 22 - Dr. Michael Hayden and PROOF-HDに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。